OrthoAxis - Product

Product Overview

#Summit 456 TLSO
PDAC Code L0456 Approved
The Summit™ 456 TLSO was designed to both aid in promoting a more natural posture and provide a low profile, post-surgical TLSO option. In terms of postural correction, the brace is designed to help re-educate a patients' muscles with the therapeutic goal to return them to a functional mid-range. For patients who do not require the motion restriction of an anterior rigid TLSO, the Summit 456 TLSO is a viable solution post-surgery as well. Because the Summit 456 TLSO is comfortable to wear and easy to don and doff, it also helps improve patient compliance. This brace is available in a one-size adjustable and in the original sized versions.

Height Options For a Customized Fit

Telescoping shoulder straps provide 13 inches of height adjustment to effectively fit patients. This, along with circumferential adjustability, helps enable a tailored fit to accommodate most body types.

Integrated Anterior Panels
Anterior panels at each end of the brace overlap to provide added midline support. Featuring Aspen's innovative FlexTabs™, these panels disperse pressure and naturally conform to each patient's anatomy to help increase comfort.

Malleable Aluminum Support
The Summit 456 TLSO aluminum support can be conformed to fit varying anatomies and is designed to help restore balance and reduce daily pain.

One Size Adjustable Featuring Aspen's Sure Slot™ System
Unique sizing mechanism allows for quick and easy sizing adjustments, without the use of tools.

Easy Access for Modification
All structural components are easily removed and can be heat molded, bent or trimmed to further customize the brace to accommodate various individual patient conditions.

(https://www.aspenmp.com/)

Aspen Medical Products Website

Brochure

Instruction Sheet

Adjustable Instruction Sheet

Patient Pamphlet

Coding Letter

Documentation Worksheet

Adjustable Documentation Worksheet

Technique Tips

Reviews

X-Rays

Visitors Also Viewed

Summit™ 456 TLSO

(0 Reviews)
(0 Comments)